The transition of ongoing studies to the EU Clinical Trials Regulation (CTR) is a heavily administrative process that takes up to three months. Trial sponsors can avoid it by acting before October 16, 2024, to select the expedited procedure. Discover how you can avoid the burden of a full process and how Lionbridge can assist with any expedited clinical trial translations for your transitioning application. Watch our video to learn more.
